우울증 환자의 약물 부작용 감당 의향
The Willingness of Enduring Drug Side Effects in the Patients of Depressive Disorders: From the Results of Korean Nationwide Patients’ Perspectives Survey Study
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives There has been increased use of medications in treating depressive disorders. Nowadays, patient value is an important part of prescribing medications. This study examines depressive patients’ perspectives on the side effects of medications. Methods We administered questionnaires nationwide to 364 patients with depressive disorders. Intent or willingness to endure 21 side effects from the Antidepressant Side-Effect Checklist (ASEC) were examined and compared in patients who are less than mildly ill and who are more than moderately ill. Results In the population, decreased appetite, yawning, increased body temperature, dry mouth, sweating, and constipation are regarded as generally endurable side effects. In contrast, dizziness, light-headedness, nausea or vomiting, headaches, disorientation, problems with urination, and difficulty sleeping are hard to endure. There were differences between patients who are less than mildly ill and those who are more than moderately ill regarding the willingness to endure drowsiness, decreased appetite, sexual dysfunction, palpitations, and weight gain. Conclusion This nationwide study revealed a general willingness in depressed patients to endure side effects. Sensitive and premeditative discussions of patient value with regard to medications might contribute to finding successful treatments.
Abstract
Objectives There has been increased use of medications in treating depressive disorders. Nowadays, patient value is an important part of prescribing medications. This study examines depressive patients’ perspectives on the side effects of medications. Methods We administered questionnaires nationwide to 364 patients with depressive disorders. Intent or willingness to endure 21 side effects from the Antidepressant Side-Effect Checklist (ASEC) were examined and compared in patients who are less than mildly ill and who are more than moderately ill. Results In the population, decreased appetite, yawning, increased body temperature, dry mouth, sweating, and constipation are regarded as generally endurable side effects. In contrast, dizziness, light-headedness, nausea or vomiting, headaches, disorientation, problems with urination, and difficulty sleeping are hard to endure. There were differences between patients who are less than mildly ill and those who are more than moderately ill regarding the willingness to endure drowsiness, decreased appetite, sexual dysfunction, palpitations, and weight gain. Conclusion This nationwide study revealed a general willingness in depressed patients to endure side effects. Sensitive and premeditative discussions of patient value with regard to medications might contribute to finding successful treatments.
참고문헌 (16)
- Gupta M, "Does evidence-based medicine apply to psychiatry?", Theor Med Bioeth, 28, pp.103~120 (2007)
- Richardson PE, "David Sackett and the birth of Evidence Based Medicine : how to practice and teach EBM", BMJ, 350, pp.h3089~ (2015)
- von Arx LB, "The patient perspective of diabetes care : a systematic review of stated preference research", Patient, 7, pp.283~300 (2014)
- Fraenkel L, "Participation in medical decision making : the patients’ perspective", Med Decis Making, 27, pp.533~538 (2007)
- Leucht S, "What does the HAMD mean?", J Affect Disord, 148, pp.243~248 (2013)
- Uher R, "Adverse reactions to antidepressants", Br J Psychiatry, 195, pp.202~210 (2009)
- Chaudhari B, "Evaluation of treatment adherence in outpatients with schizophrenia", Ind Psychiatry J, 26, pp.215~222 (2017)
- Thompson K, "Reliability and validity of a new Medication Adherence Rating Scale(MARS)for the psychoses", Schizophr Res, 42, pp.241~247 (2000)
- Wykes T, "What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication", Psychol Med, 47, pp.2369~2378 (2017)
- Mahtani-Chugani V, "Antidepressant management strategy from the patient perspective : struggling internally and externally", Aten Primaria, 44, pp.463~470 (2012)
- Torta RG, "Antidepressant up-titration : pharmacological and psychological considerations", Expert Opin Drug Saf, 11, pp.685~688 (2012)
- Dold M, "Dose escalation of antidepressants in unipolar depression: a meta-analysis of double-blind, randomized controlled trials", Psychother Psychosom, 86, pp.283~291 (2017)
- Bet PM, "Side effects of antidepressants during long-term use in a naturalistic setting", Eur Neuropsychopharmacol, 23, pp.1443~1451 (2013)
- Montejo AL, "Sexual side-effects of antidepressant and antipsychotic drugs", Curr Opin Psychiatry, 28, pp.418~423 (2015)
- Haddad PM, "Nonadherence with antipsychotic medication in schizophrenia : challenges and management strategies", Patient Relat Outcome Meas, 5, pp.43~62 (2014)
- Hamann J, "Shared decision making in psychiatry", Acta Psychiatr Scand, 107, pp.403~409 (2003)